✦ LIBER ✦

Etanercept as prophylactic psoriatic therapy before interferon-α and ribavirin treatment for active hepatitis C infection

✍ Scribed by S. E. Behnam; R. Hindiyeh; D. J. Fife; E. W. Jeffes III; J. J. Wu

Book ID: 108695379
Publisher: John Wiley and Sons
Year: 2010
Tongue: English
Weight: 51 KB
Volume: 35
Category: Article
ISSN: 0307-6938
DOI: 10.1111/j.1365-2230.2009.03476.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Modifications of T-Lymphocyte Subsets be

Modifications of T-Lymphocyte Subsets before and during Interferon and Ribavirin Treatment for Chronic Hepatitis C Infection

✍ Neau-Cransac, Martine; Foucher, Juliette; Ledinghen, Victor De; Bernard, Pierre- 📂 Article 📅 2005 🏛 Mary Ann Liebert 🌐 English ⚖ 94 KB

Combination of interferon-α and ribaviri

Combination of interferon-α and ribavirin therapy for recurrent hepatitis C virus infection after liver transplantation

✍ Z Ben-Ari; E Mor; E Shaharabani; N Bar-Nathan; Z Shapira; R Tur-Kaspa 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 60 KB

Etanercept as an adjuvant to interferon

Etanercept as an adjuvant to interferon and ribavirin in treatment-naive patients with chronic hepatitis C virus infection: a phase 2 randomized, double-blind, placebo-controlled study

✍ Nizar N. Zein; for the Etanercept Study Group 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 176 KB

Efficacy and Safety of Pegylated Interfe

Efficacy and Safety of Pegylated Interferon- α 2b Plus Ribavirin for the Treatment of Chronic Hepatitis C in HIV-Infected Patients

✍ Santin, Miguel; Shaw, Evelyn; Garcia, M. Jose; Delejido, Antonio; De Castro, Edu 📂 Article 📅 2006 🏛 Mary Ann Liebert 🌐 English ⚖ 107 KB

Therapy with interferon-α and ribavirin

Therapy with interferon-α and ribavirin for chronic hepatitis C virus infection upregulates membrane HLA-ABC, CD86, and CD28 on peripheral blood mononuclear cells

✍ Pin-Nan Cheng; Ya-Ling Wei; Ting-Tsung Chang; Jiann-Shiuh Chen; Kung-Chia Young 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 125 KB

## Abstract Multiple interferon‐stimulated genes (ISGs) involving T‐cell activation are upregulated during initial interferon‐α‐based therapy for chronic hepatitis C virus (HCV) infection. However, the long‐term impact on therapeutic outcome in patients remains unknown. In this study, the effects o

Treatment effects and predictors of a 24

Treatment effects and predictors of a 24-week course of interferon α-2b plus ribavirin combination therapy for patients with chronic hepatitis C

✍ Masahiko Tomimatsu; Yoshio Aizawa; Yoshimichi Chuganji; Hideo Ishizuka; Yoshiyuk 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 171 KB